Pharma has been a very active sector for M&A. With the Salix acquisition not expected until the second quarter, this should help put some space between these two big bond deals. Julie Stralow More Quotes by Julie Stralow More Quotes From Julie Stralow Salix is a leader in the gastrointestinal market, which is comprised primarily of small-to-mid-sized pharmaceutical competitors, typically Valeant thrives in niches that tend to be overlooked by larger pharmaceutical firms. Julie Stralow company-news
